KUKJEON PHARMACEUTICAL Co., Ltd (KOSDAQ:307750)
South Korea
· Delayed Price · Currency is KRW
3,505.00
+10.00 (0.29%)
At close: Dec 5, 2025
KUKJEON PHARMACEUTICAL Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 175,868 | 172,478 | 306,192 | 324,839 | 537,308 |
| Market Cap Growth | -13.32% | -43.67% | -5.74% | -39.54% | - |
| Enterprise Value | 196,636 | 178,557 | 319,290 | 284,635 | - |
| Last Close Price | 3505.00 | 3515.00 | 6222.17 | 6590.26 | 10900.81 |
| PE Ratio | - | 99.34 | 63.47 | 36.30 | 133.06 |
| PS Ratio | 1.32 | 1.26 | 2.51 | 3.13 | 6.30 |
| PB Ratio | 1.79 | 1.77 | 3.14 | 3.52 | 6.46 |
| P/TBV Ratio | 1.81 | 1.80 | 3.22 | 3.60 | 6.50 |
| P/FCF Ratio | 1065.41 | 79.52 | - | - | - |
| P/OCF Ratio | 52.65 | 17.19 | - | - | 176.63 |
| EV/Sales Ratio | 1.48 | 1.31 | 2.62 | 2.75 | - |
| EV/EBITDA Ratio | 283.46 | 32.63 | 33.11 | 57.72 | - |
| EV/EBIT Ratio | - | 486.92 | 49.05 | 81.60 | - |
| EV/FCF Ratio | 1191.22 | 82.32 | - | - | - |
| Debt / Equity Ratio | 0.45 | 0.67 | 0.81 | 0.64 | 0.09 |
| Debt / EBITDA Ratio | 52.77 | 11.94 | 8.17 | 12.03 | 1.09 |
| Debt / FCF Ratio | 270.47 | 30.11 | - | - | - |
| Asset Turnover | 0.65 | 0.62 | 0.58 | 0.68 | - |
| Inventory Turnover | 5.07 | 4.22 | 4.05 | 4.62 | - |
| Quick Ratio | 0.78 | 0.85 | 0.94 | 1.67 | 2.72 |
| Current Ratio | 1.16 | 1.19 | 1.24 | 2.02 | 3.52 |
| Return on Equity (ROE) | -4.38% | 0.55% | 4.95% | 10.12% | - |
| Return on Assets (ROA) | -1.33% | 0.10% | 1.93% | 1.44% | - |
| Return on Capital (ROIC) | -1.71% | 0.14% | 2.48% | 1.80% | - |
| Return on Capital Employed (ROCE) | -3.80% | 0.30% | 5.20% | 2.80% | 7.20% |
| Earnings Yield | -2.06% | 1.01% | 1.58% | 2.76% | 0.75% |
| FCF Yield | 0.09% | 1.26% | -14.46% | -9.02% | -1.37% |
| Dividend Yield | 0.29% | 0.28% | - | - | - |
| Payout Ratio | - | 28.26% | - | 5.48% | - |
| Buyback Yield / Dilution | -2.21% | - | 4.23% | -16.16% | - |
| Total Shareholder Return | -1.92% | 0.28% | 4.23% | -16.16% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.